Drugs / Natural killer cell
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03358849 | Oct 2017 → Sep 2018 | biliary tract cancer | Yonsei University | Completed | No outcome recorded |
| Phase 1/24 trials | ||||||
| Phase 1/2 | NCT02844335 | Jul 2016 → Jul 2017 | female breast carcinoma | Fuda Cancer Hospital, Guangzhou | Completed | No outcome recorded |
| Phase 1/2 | NCT02843815 | Jul 2016 → Jul 2017 | non-small cell lung carcinoma | Fuda Cancer Hospital, Guangzhou | Completed | No outcome recorded |
| Phase 1/2 | NCT02849015 | Jul 2016 → Jul 2017 | liver cancer | Fuda Cancer Hospital, Guangzhou | Completed | No outcome recorded |
| Phase 1/2 | NCT02843802 | Jul 2016 → Jul 2017 | secondary malignant neoplasm | Fuda Cancer Hospital, Guangzhou | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT05754684 | Jan 2022 → Dec 2025 overdue | neuroblastoma | Hong Kong Children's Hospital | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Natural killer cell | “Natural killer cell (each treatment: about 10 billion cells transfusion in 3 times, i.v.)” NCT02843802 ↗5“Natural killer cell (each treatment: about 10 billion cells transfusion in 3 times, i.v.)” NCT02844335 ↗ “Natural killer cell (each treatment: about 10 billion cells transfusion in 3 times, i.v.)” NCT02843815 ↗ “Natural killer cell(each treatment: about 10 billion cells transfusion in 3 times, i.v.)” NCT02849015 ↗ |
| Action | Deplete | “it is a cytotoxic cell that can immediately remove cancer cells without any other activation process” NCT03358849 ↗ |
| Modality | Cell therapy | “Natural killer cell” NCT02843802 ↗ |
| Route | Intravenous | “i.v.” NCT02843802 ↗ |